Kabra Drugs Ltd vs DIVI S LABORATORIES LTD
A side-by-side comparison of Kabra Drugs Ltd (524322) and DIVI S LABORATORIES LTD (DIVISLAB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, DIVI S LABORATORIES LTD leads 524322 vs DIVISLAB on 9 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability13
- Growth· not comparable—
- Size & financial health04
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
DIVISLAB takes 3/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
DIVISLAB takes 4/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free."]
- − ["Company has a low return on equity of 7.79% over last 3 years.", "Company has high debtors of 279 days."]
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
- − ["Stock is trading at 14.8 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.